Latest Breaking News On - Diversified biopharmaceuticals - Page 1 : comparemela.com

Regeneron Pharmaceuticals shares rose 10% following positive Phase III data for Dupixent® in chronic obstructive pulmonary disease (COPD).

United statesIsrael generalKiryat gatDane leoneCodiak biosciencesDavid risingerRegeneron velocisuiteBrianp skorneyHans engelDouglase williamsAndrew obenshainCarter gouldMohit bansalAkash tewariChris schottSonoma biotherapeutics